Document Detail


Diabetic ketoacidosis (DKA): treatment guidelines.
MedLine Citation:
PMID:  8804545     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Diabetic ketoacidosis (DKA), resulting from severe insulin deficiency, accounts for most hospitalization and is the most common cause of death, mostly due to cerebral edema, in pediatric diabetes. This article provides guidelines on management to restore perfusion, stop ongoing ketogenesis, correct electrolyte losses, and avoid hypokalemia and hypoglycemia and the circumstances that may contribute, in some instances, to cerebral edema (overhydration, rapid osmolar shifts, hypoxia). These guidelines emphasize the importance of monitoring glycemia, electrolytes, hydration, vital signs, and neurologic status in a setting where response can be rapid if necessary (e.g., mannitol for cerebral edema). Most important is the prevention of DKA in established patients by close supervision of those most likely to omit insulin, or during illness, and a high index of suspicion for diabetes to prevent deterioration to DKA in new patients, particularly those under age 5, who are at greatest risk of complications.
Authors:
A L Rosenbloom; R Hanas
Related Documents :
6768135 - Low-dose insulin for treatment of diabetic ketoacidosis in a private community hospital.
6409465 - Glucose and ketone body kinetics in diabetic ketoacidosis.
18191075 - Body fluid abnormalities in severe hyperglycemia in patients on chronic dialysis: revie...
6802695 - Impaired insulin binding to isolated adipocytes in experimental diabetic ketoacidosis.
22772755 - Enhancement of 26s proteasome functionality connects oxidative stress and vascular endo...
19175375 - Insulin therapy in type 2 diabetes: what is the evidence?
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical pediatrics     Volume:  35     ISSN:  0009-9228     ISO Abbreviation:  Clin Pediatr (Phila)     Publication Date:  1996 May 
Date Detail:
Created Date:  1996-10-23     Completed Date:  1996-10-23     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  0372606     Medline TA:  Clin Pediatr (Phila)     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  261-6     Citation Subset:  AIM; IM    
Affiliation:
Department of Pediatrics, University of Florida College of Medicine, Gainesville 32610-0296, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Brain Diseases / complications
Case Management
Child
Child, Preschool
Clinical Protocols
Dehydration / therapy
Diabetic Ketoacidosis / complications,  diagnosis,  therapy*
Drug Administration Schedule
Fluid Therapy
Humans
Hyperglycemia / therapy
Hypoglycemia / chemically induced,  prevention & control,  therapy
Hypokalemia / therapy
Infant
Insulin / administration & dosage,  adverse effects
Insulin Infusion Systems
Chemical
Reg. No./Substance:
11061-68-0/Insulin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Amphotericin B lipid complex treatment of a leukemic child with disseminated Fusarium solani infecti...
Next Document:  The effect of ondansetron on pyridostigmine-induced blood acetylcholinesterase inhibition in the gui...